Trimethylamine-N-oxide as a Marker for Diabetic Retinopathy
Author Information
Author(s): Yakar Burkay, Onalan Erhan, Kaymaz Tugce, Donder Emir, Gursu Mehmet Ferit
Primary Institution: Firat University
Hypothesis
Can plasma trimethylamine N-oxide level be a novel marker in the diagnosis of diabetic retinopathy and differentiate between diabetic and nondiabetic retinopathy?
Conclusion
The study found that trimethylamine N-oxide levels are elevated in diabetic retinopathy, suggesting it could be a novel marker for the condition.
Supporting Evidence
- Trimethylamine N-oxide level was significantly higher in diabetic retinopathy than in other groups.
- There was a significant positive correlation between trimethylamine N-oxide level and elevated fasting plasma glucose, BMI, and inflammatory markers.
- The study included a total of 120 participants across four groups.
Takeaway
This study looked at a substance called trimethylamine N-oxide to see if it can help doctors tell if someone has a type of eye problem caused by diabetes. They found that higher levels of this substance are linked to the eye problem.
Methodology
The study included 30 patients each from four groups: diabetic retinopathy, nondiabetic retinopathy, type 2 diabetes without retinopathy, and healthy controls, measuring various biochemical parameters.
Limitations
The study had a relatively small number of patients from the same ethnicity and did not standardize factors affecting diabetic complications.
Participant Demographics
Participants aged 40-75 years, including both genders, with a total of 120 individuals across four groups.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website